文献速递胸部肿瘤放疗消化道肿瘤放疗放疗物理与技术

预测放射性心脏毒性的血浆代谢物标志物

Plasma metabolite biomarkers predictive of radiation induced cardiotoxicity.
PubMed 文献 · Radiother Oncol · 2020-04-20

该研究分析受照大鼠血浆与左心室组织及接受高剂量胸部放疗的食管癌患者血浆,利用代谢组学和脂质组学寻找放射性心脏毒性相关标志物,发现类固醇激素生物合成与维生素E代谢等共性改变,并据此构建预测患者放射性心脏病风险的分类算法。

要点

  • 大鼠与患者血浆均显示类固醇激素生物合成和维生素E代谢的辐射响应改变。
  • 患者血浆代谢谱变化被用于开发预测放射性心脏病风险的分类算法。
  • 研究初步证明基于代谢组学的生物标志物组合用于放射性心脏毒性风险评估的可行性。

核心结论

  • 研究报道了开发基于代谢组学的生物标志物组合的可行性,该组合与接受食管癌放疗患者心功能不良结局相关。

研究设计与样本

  • 研究分析了一组雄性Sprague Dawley大鼠的血浆和左心室心脏组织样本,大鼠接受假照射或心脏靶向X线分次照射(每天9 Gy×5天)。
  • 研究采用代谢组学和脂质学分析作为关联方法,以 delineate 与放射性心脏毒性相关的新型生物标志物。
  • 研究使用高分辨率质谱检查接受高剂量胸部放疗的食管癌患者血浆样本的代谢谱。

主要发现

  • 大鼠模型和患者血浆谱的代谢改变显示出辐射响应的共性,包括类固醇激素生物合成和维生素E代谢。

临床怎么用

  • 研究提示血浆代谢组学分析或可用于预测接受胸部放疗患者发生放射性心脏病的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although advancements in cancer treatments using radiation therapy (RT) have led to improved outcomes, radiation-induced heart disease (RIHD) remains a significant source of morbidity and mortality in survivors of cancers in the chest. Currently, there are no diagnostic tests in clinical use due to a lack of understanding of the natural history and mechanisms of RIHD development. Few studies have examined the utility of using metabolomics to prospectively identify cancer survivors who are at risk of developing cardiotoxicity. METHODS: We analyzed plasma and left ventricle heart tissue samples collected from a cohort of male Sprague Dawley (SD) rats that were either sham irradiated or received fractionated doses (9 Gy per day × 5 days) of targeted X-ray radiation to the heart. Metabolomic and lipidomic analyses were utilized as a correlative approach for delineation of novel biomarkers associated with radiation-induced cardiac toxicity. Additionally, we used high-resolution mass spectrometry to examine the metabolomic profiles of plasma samples obtained from patients receiving high dose thoracic RT for esophageal cancer. RESULTS: Metabolic alterations in the rat model and patient plasma profiles, showed commonalities of radiation response that included steroid hormone biosynthesis and vitamin E metabolism. Alterations in patient plasma profiles were used to develop classification algorithms predictive of patients at risk of developing RIHD. CONCLUSION: Herein, we report the feasibility of developing a metabolomics-based biomarker panel that is associated with adverse outcomes of cardiac function in patients who received RT for the treatment of esophageal cancer.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Unger K, Li Y, Yeh C, et al. Plasma metabolite biomarkers predictive of radiation induced cardiotoxicity. Radiother Oncol. 2020. PMID: 32360032. doi:10.1016/j.radonc.2020.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。